关注
Abarna R
Abarna R
CMCH
在 cmcvellore.ac.in 的电子邮件经过验证
标题
引用次数
引用次数
年份
Photocatalytic degradation of synthetic food dye, sunset yellow FCF (FD&C yellow no. 6) by Ailanthus excelsa Roxb. possessing antioxidant and cytotoxic activity
S Deepika, R Harishkumar, M Dinesh, R Abarna, M Anbalagan, ...
Journal of Photochemistry and Photobiology B: Biology 177, 44-55, 2017
302017
Effect of Arg399Gln single-nucleotide polymorphism in XRCC1 gene on survival rate of Indian squamous cell head-and-neck cancer patients
D Dutta, R Abarna, S Mehatre, K Subbiah, S Duraisamy, R Chinnusamy, ...
journal of cancer research and therapeutics 16 (3), 551-558, 2020
82020
Novel peptide—based inhibitor for targeted inhibition of T cell function
A Gauthaman, R Jacob, S Pasupati, A Rajadurai, CGP Doss, A Moorthy
Journal of Cell Communication and Signaling 16 (3), 349-359, 2022
62022
Identification of novel heterozygous Apex 1 gene variant (Glu87Gln) in patients with head and neck cancer of Indian origin
R Abarna, D Dutta, P Sneha, C George Priya Doss, M Anbalagan
Journal of Cellular Biochemistry 119 (11), 8851-8861, 2018
42018
Analysis of patients with endometrial carcinoma using the ProMise classifier: a pilot study from India
A Dahiya, A Rajadurai, S Daniel, A Sebastian, DS Thomas, V Thomas, ...
Archives of Gynecology and Obstetrics 309 (4), 1499-1508, 2024
22024
Comparative analysis of mutational patterns in triple negative breast cancer before and after neoadjuvant chemotherapy in patients with residual disease
A Singh, JT Georgy, S Dhananjayan, E Sigamani, AO John, A Joel, ...
Gene 895, 147980, 2024
12024
Droplet digital PCR (ddPCR) using FFPE DNA to assess methylation status of MGMT gene among patients with IDH mutant astrocytoma and IDH wild-type glioblastoma
R Abarna, J Ranjani, R Pai
Journal of Clinical Pathology 76 (12), 860-864, 2023
12023
EV331/# 1154 Molecular and immunohistochemistry profile correlation with unique behavior of low grade serous cancers of ovary
A Thomas, NR Sindhu, H Das, D Thomas, V Thomas, A Sebastian, ...
International Journal of Gynecologic Cancer 34 (Suppl 3), 2024
2024
Analysis of the effect of baseline detection and early clearance of ct-DNA, on survival outcomes among patients with advanced EGFR-mutant non-small cell lung cancer
A Joel, R Abarna, RT Chacko, A Singh, JT Georgy, AO John, DB Thumaty, ...
Klinicka onkologie: casopis Ceske a Slovenske onkologicke spolecnosti 38 (1 …, 2024
2024
Subclonal evolution in the mutational landscape of early Triple negative breast cancer (TNBC) on multi-agent chemotherapy: Comparison of Pre-And Post-Neoadjuvant Chemotherapy …
A Singh, JT Georgy, S Dhananjayan, E Sigamani, AO John, A Joel, ...
2022
A Pilot study of POLE mutations in endometrial cancer and its clinicopathological correlation with Microsatellite Instability and P53 mutations
A Dahiya, A Thomas, R Pai, A Rajadurai, S Daniel, A Sebastian, ...
2022
Diagnostic utility of droplet digital PCR to detect TERT promoter mutations among glioblastoma samples using 7-deaza-dGTP
R Abarna, R Nancy, A Chacko, G Chacko, R Pai
Journal of Clinical Pathology 75 (2), 140-142, 2022
2022
E Poster Presentation
S Singh, M Gupta, V Nautiyal, R Kumar, BP Kalra, K Das, N Shirazi, ...
International Journal of Neurooncology 4 (2), 84-110, 2021
2021
Identification of novel mutation in APE1 gene in head and neck cancer patient
D Dutta, R Abarna, V Kannan, Sreeprakash, C Rayappa, M Anbalagan
EUROPEAN JOURNAL OF CANCER 54, S2-S3, 2016
2016
Evaluating Subclonal Evolution and Mutational Dynamics in Triple-Negative Breast Cancer Patients with Residual Disease: A Comparison of Pre-and Post-Neoadjuvant Chemotherapy
A Singh, JT Georgy, S Dhananjayan, E Sigamani, A John, A Joel, ...
系统目前无法执行此操作,请稍后再试。
文章 1–15